Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Each month we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Heat Biologics has devised a method intended to capture poly-antigens and present them to immunomodulatory mechanisms and revitalize the immune system, allowing it to target and annihilate cancer.
Dr. Adler provides a detailed review of the diagnostic criteria associated with adult attention-deficit / hyperactivity disorder (ADHD) due to the complex constellation of symptoms that mimic or…
The United States National Institutes of Health (US NIH) has collaborated with an established pharmaceutical company, Sanofi, in an attempt to foment a revolutionary medical breakthrough in HIV…
